ClinVar Miner

Submissions for variant NM_000051.3(ATM):c.67C>T (p.Arg23Ter) (rs746235533)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 4
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Ambry Genetics RCV000215307 SCV000276332 pathogenic Hereditary cancer-predisposing syndrome 2017-10-19 criteria provided, single submitter clinical testing Lines of evidence used in support of classification: Alterations resulting in premature truncation (e.g.reading frame shift, nonsense)
GeneDx RCV000579150 SCV000680683 pathogenic not provided 2018-03-12 criteria provided, single submitter clinical testing This variant is denoted ATM c.67C>T at the cDNA level and p.Arg23Ter (R23X) at the protein level. Thesubstitution creates a nonsense variant, which changes an Arginine to a premature stop codon (CGA>TGA), and ispredicted to cause loss of normal protein function through either protein truncation or nonsense-mediated mRNA decay.This variant has been observed in at least one individual with mantle cell lymphoma and one individual with gastriccancer (Camacho 2002, Huang 2015). We consider this variant to be pathogenic
Invitae RCV000627840 SCV000748724 pathogenic Ataxia-telangiectasia syndrome 2018-11-02 criteria provided, single submitter clinical testing This sequence change creates a premature translational stop signal (p.Arg23*) in the ATM gene. It is expected to result in an absent or disrupted protein product. This variant is present in population databases (rs746235533, ExAC 0.006%). This variant has been reported in an individual affected with mantle cell lymphoma (PMID: 11756177) and in an individual affected with gastric cancer. (PMID: 26506520). ClinVar contains an entry for this variant (Variation ID: 232248). Loss-of-function variants in ATM are known to be pathogenic (PMID: 23807571, 25614872). For these reasons, this variant has been classified as Pathogenic.
Color RCV000215307 SCV000913525 pathogenic Hereditary cancer-predisposing syndrome 2018-02-14 criteria provided, single submitter clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.